ArticleSchmerz (Berlin, Germany)2026
[Structural and process parameters of interdisciplinary multimodal pain therapy in Germany-an update].
Article in Schmerz (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interdisciplinary multimodal pain therapy (IMST) for patients suffering from chronic pain is well-established in the treatment algorithm. Usually, this treatment is performed over a minimum of one to a maximum of four weeks in an inpatient or alternatively in a day-clinic setting. For maintaining the primary treatment results, so-called booster sessions may be implemented. In spring 2025 a survey among facilities providing IMST in Germany was conducted. Additionally, data were analyzed from a nation-wide clinic registry starting with data from 2013. The aim of the study was to describe the current situation of IMST in Germany.The overall number of inpatient treatment facilities decreased (2013: 426; 2025: 298) whereas the number of day-clinic facilities increased (2013: 39; 2025: 100). In both settings the number of treatments increased significantly (day clinic: +293%; inpatient treatment: +31%). More than 50% of all responding facilities reported providing a booster-session. However, relevant disparities between inpatient and day-clinic IMST concerning maintenance strategies could be detected.
Indexed as
Identifiers
42059912What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.